Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal
FierceBiotech - 26-Jul-2025Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Join the club for FREE to access the whole archive and other member benefits.
Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
UK project aims to build human DNA from scratch, raising hopes for cures—and ethical concerns
Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets
Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing
ForSight’s $125M boost powers eye-surgery robot tested in 300 pig-eye trials, human ops next
It may be a potential one-time seasonal alternative to vaccines without serious side effects
New platform aims to cut drug discovery by $2B and 9 years using lab-grown human immune models
AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss
SB-007 enters phase 1/2 trials to restore vision in Stargardt disease using novel splicing tech
New tech delivers same-day results to improve prescriptions and curb rising antimicrobial resistance
Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push
Biotech firm uses AI and robotics to test drugs on real human tissues, not animals
Biotech firm to create skilled jobs as it scales innovative platform for healthier ageing therapies
The company is still in early stages but attracting strong investor interest
India partnerships and FDA progress boost future income
Biotech pivots to drug combo after monotherapy safety and efficacy setbacks
Valve CEO’s BCI firm builds battery-free chip to interact with multiple brain regions
Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
Berlin startup freezes bodies, hoping for future revival
Juvenescence expands pipeline and UAE presence with new funding to tackle age-related diseases
Regeneron buys 23andMe for $256M, pledges to protect user data and boost drug discovery
Somite AI uses DeltaStem to speed up and scale stem cell engineering
Unlocking ageing science could add decades of life—but funding is the missing link
Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma
Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states